News | May 11, 2021
Alembic reports net profit of Rs. 71.94 Cr in Q4FY21
Alembic has reported total income of Rs.83.79 crores during the FY ended March 31, 2021
Alembic has reported total income of Rs.83.79 crores during the FY ended March 31, 2021
Seven manufacturers of Remdesivir have increased production capacity to 1.03 crore vials per month up from 38 lakh vials per month a month ago
R&D Centre will be housed in Baddi and will cater to all business divisions in addition to expansion plans for all its verticals including APls, Formulations and Medical Devices
The company will be requesting a Compulsory License based on emergency use and in light of the grave and serious public health emergency across India due to the Pandemic
Gujarat Themis Biosyn has reported total income of Rs.93.82 crores for FY 2020-21
Dr. Reddy’s Albendazole Tablets, USP are available in 200 mg tablets in bottle count sizes of two
In animal health, the products will be mainly targeting mastitis and production disorders, gastrointestinal tract diseases, reproductive disorders, ectoparasites, and skin injuries
These media reports are based on incorrect facts and are without any basis.
_256_384.jpeg)
Against the present demand from 20 states of 6,785 MT/day of Liquid Medical Oxygen, the Government of India has from 21st April allocated 6,822 MT/day to these states
Subscribe To Our Newsletter & Stay Updated
